Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Cholangiocarcinoma × temoporfin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2 Carcinoma, Squamous Cell 2 Carcinoma, Non-Small-Cell Lung 2 Tongue Neoplasms 1 Neoplasms 1 Lung Neoplasms 1 Klatskin Tumor 1 Head and Neck Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Large Cell 1 Adenocarcinoma 1

Interventions

Gemcitabine 69 Cisplatin 41 Oxaliplatin 31 lenvatinib 22 durvalumab 21 Capecitabine 21 Fluorouracil 18 Leucovorin 13 pembrolizumab 10 apatinib 10 Radiotherapy 10 Radiofrequency Ablation 9 Albumin-Bound Paclitaxel 9 tislelizumab 8 Taxes 7 Magnetic Resonance Spectroscopy 7 Liver Transplantation 7 Floxuridine 7 Drug Therapy 7 Cholangiopancreatography, Endoscopic Retrograde 7 tremelimumab 6 pemigatinib 6 Surgical Procedures, Operative 6 Photochemotherapy 6 Panitumumab 6 Irinotecan 6 Folfox protocol 6 130-nm albumin-bound paclitaxel 6 sintilimab 5 camrelizumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03003065 2023-08-22

PDT

Chinese University of Hong Kong

Phase 2 Completed

Gastrointestinal

Neoplasms, Cholangiocarcinoma, Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡